Download PDF
Thromb Haemost 1979; 41(03): 576-582
DOI: 10.1055/s-0038-1646810
Original Articles
Schattauer GmbH Stuttgart

A in Vivo Assay for Standardizing Heparin Preparations

A R Pomeroy
The National Biological Standards Laboratory, Department of Health Canberra, A. C. T., Australia
› Author Affiliations
Further Information

Publication History

Received 21 April 1978

Accepted 08 June 1978

Publication Date:
09 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The limitations of currently used in vitro assays of heparin have demonstrated the need for an in vivo method suitable for routine use.

The in vivo method which is described in this paper uses, for each heparin preparation, four groups of five mice which are injected intravenously with heparin according to a “2 and 2 dose assay” procedure. The method is relatively rapid, requiring 3 to 4 hours to test five heparin preparations against a standard preparation of heparin. Levels of accuracy and precision acceptable for the requirements of the British Pharmacopoeia are obtained by combining the results of 3 to 4 assays of a heparin preparation.

The similarity of results obtained the in vivo method and the in vitro method of the British Pharmacopoeia for heparin preparations of lung and mucosal origin validates this in vivo method and, conversely, demonstrates that the in vitro method of the British Pharmacopoeia gives a reliable estimation of the in vivo activity of heparin.

 

  • References

  • 1 Bangham DR, Woodward PM. 1970; A collaborative study of heparins from different sources. Bulletin of the World Health Organization 42: 129
    PubMedSearch in Google Scholar
  • 2 Blomback B, Blomback M, Corneliusson EV, Jorpes JE. 1953; On the reliability of the methods used in the assay of heparin. Journal of Pharmacy and Pharmacology 5: 1031
    CrossrefPubMedSearch in Google Scholar
  • 3 British Pharmacopoeia. 1968. Her Majesty’s Stationery Office; London: P 1296
  • 4 British Pharmacopoeia. 1973. Her Majesty’s Stationery Office; London: P A 112
  • 5 Jorpes EJ, Blomback M, Blomback B. 1954; An in vivo method for the assay of heparin. Journal of Pharmacy and Pharmacology 6: 694
    CrossrefPubMedSearch in Google Scholar
  • 6 Kuo SH, Jaques LB, Millar GJ. 1972; An improved in vivo procedure for standardization of heparin preparations. Journal of Pharmacy and Pharmacology 24: 858
    CrossrefPubMedSearch in Google Scholar
  • 7 Rezansoff WE, Jaques LB. 1967; An investigation of the assay of heparin based on its activity in vivo. Thrombosis et Diathesis Haemorrhagica 18: 150
    PubMedSearch in Google Scholar
  • 8 Walton PL, Ricketts CR, Bangham DR. 1966; Heterogeneity of heparin. British Journal of Haematology 12: 310
    CrossrefPubMedSearch in Google Scholar
  • 9 W.H.O. Expert Committee On Biological Standardization. 1969; Heparins. World Health Organization Technical Report Series 413: 17
    PubMedSearch in Google Scholar